Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AIFA
Description:
AIFA is Italy’s national medicines agency, responsible for regulating pharmaceutical products and supporting their safe and effective use.
Primary topic:
Pharmaceutical Economics and Policy (41%)
Related topics:
Pharmaceutical Economics and Policy (41%),
Health Systems, Economic Evaluations, Quality of Life (8%)
OpenAlex ID:
keywords/aifa
Italian risk-sharing agreements on drugs: are they worthwhile?
2014
·
Livio Garattini
, Alessandro Curto
, et al.
·
The European Journal of Health Economics
·
126
PDF
Farnesol induces the transcriptional accumulation of the Aspergillus nidulans Apoptosis‐Inducing Factor (AIF)‐like mitochondrial oxidoreductase
2008
·
Marcela Savoldi
, Iran Malavazi
, et al.
·
Molecular Microbiology
·
71
PDF
Pricing and reimbursement of pharmaceuticals in Italy
2008
·
Pietro Folino-Gallo
, Simona Montilla
, et al.
·
The European Journal of Health Economics
·
69
The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy
2021
·
Entela Xoxi
, Karen M Facey
, et al.
·
Frontiers in Pharmacology
·
56
PDF
Risk sharing agreements: What lessons from Italy?
2011
·
Livio Garattini
, Gianluigi Casadei
·
International Journal of Technology Assessment in Health Care
·
43
Off-label drugs use in pediatric palliative care
2018
·
Lucia De Zen
, Federico Marchetti
, et al.
·
The Italian Journal of Pediatrics/Italian journal of pediatrics
·
40
PDF
The Last Decade of Italian Pharmaceutical Policy: Instability or Consolidation?
2008
·
Giovanni Fattore
, Claudio Jommi
·
PharmacoEconomics
·
35
The roles played by Aspergillus nidulans apoptosis-inducing factor (AIF)-like mitochondrial oxidoreductase (AifA) and NADH-ubiquinone oxidoreductases (NdeA-B and NdiA) in farnesol resistance
2010
·
Taísa Magnani Dinamarco
, Bárbara de Castro Figueiredo Pimentel
, et al.
·
Fungal Genetics and Biology
·
34
PDF
The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence
2017
·
Antonino Capizzi
, Michela Silvestri
, et al.
·
The Italian Journal of Pediatrics/Italian journal of pediatrics
·
30
PDF
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials
2021
·
Diego Alejandro Dri
, Carlotta Marianecci
, et al.
·
Pharmaceutics
·
27
PDF
Timeline of Authorization and Reimbursement for Oncology Drugs in Italy in the Last 3 Years
2017
·
Mariangela Prada
, Matteo Ruggeri
, et al.
·
Medicine Access Point of Care
·
26
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system
2021
·
Carlotta Galeone
, Paolo Bruzzi
, et al.
·
BMJ Open
·
25
PDF
Do France, Germany, and Italy agree on the added therapeutic value of medicines?
2023
·
Giorgio Casilli
, Dario Lidonnici
, et al.
·
International Journal of Technology Assessment in Health Care
·
24
PDF
Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines
2014
·
Livio Garattini
, Katelijne Van de Vooren
, et al.
·
Journal of the Royal Society of Medicine
·
23
PDF
Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
2013
·
Chiara Giofrè
, Francesca Scicchitano
, et al.
·
Journal of Pharmacology and Pharmacotherapeutics
·
23
PDF
Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness in the Italian reality
2023
·
Maurizio Capuozzo
, Venere Celotto
, et al.
·
The European Journal of Health Economics
·
22
PDF
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
2023
·
Carlo Torti
, Pier Paolo Olimpieri
, et al.
·
The Lancet Regional Health - Europe
·
21
Programmed Cell Death Facilitates the Formation of Unisexual Male and Female Flowers in Persimmon (Diospyros kaki Thunb.)
2020
·
Liyuan Wang
, Huawei Li
, et al.
·
Agronomy
·
20
PDF
SARS-CoV2 Vaccination Adverse Events Trend in Italy: A Retrospective Interpretation of the Last Year (December 2020–September 2021)
2022
·
Nicola Di Fazio
, Giuseppe Delogu
, et al.
·
Vaccines
·
18
PDF
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
2021
·
Sara Bravaccini
, Roberta Maltoni
·
Journal of Personalized Medicine
·
14
PDF
Aspergillus fumigatus mitogenomes and their influence on azole-resistant and -susceptible populations
2025
·
Endrews Delbaje
, Laís Pontes
, et al.
·
npj Antimicrobials and Resistance
·
9
PDF
Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies
2022
·
Entela Xoxi
, Rossella Di Bidino
, et al.
·
Frontiers in Medical Technology
·
9
PDF
Generic Medicines and Second Medical Use Patents: Litigation or Regulation? An Overview of Recent European Case Law and Practice
2018
·
Gabriel Cuonzo
, Daniela Ampollini
·
IIC - International Review of Intellectual Property and Competition Law
·
9
Accesso precoce al mercato: dalle approvazioni condizionate di EMA agli accordi negoziali particolari di AIFA
2018
·
Federico Villa
, Claudio Jommi
, et al.
·
Global & Regional Health Technology Assessment
·
9
PDF
Lessons for Adaptive Licensing: Analysis of Conditionally Approved EMA Compounds, Their Reimbursement Status and Regulatory/Reimbursement Data Requirements
2014
·
P.A. Spearpoint
, C.Y. Yip
, et al.
·
Value in Health
·
8
PDF
Show more works
View as search
Works count:
253
Citation count:
931
Year
Topic
Type